Saudi Arabia-based Hakeem Health, a health-tech company developing an AI-powered medical assistant for clinicians, has closed a $1.65 million funding round. The investment was led by Saudi firm Merak Capital, with participation from Sanabil 500.
Quick Facts
- Funding Amount: $1.65 million
- Lead Investor: Merak Capital
- Key Goal: GCC institutional adoption
An AI Co-Pilot for GCC Clinicians
Hakeem Health is focused on reducing medical errors and improving patient care through its flagship platform, HakeemDx. The clinical decision support engine integrates directly with existing hospital systems like Electronic Medical Records (EMRs) and lab platforms.
The tool provides clinicians with real-time, evidence-based guidance in both Arabic and English at the point of care. By operating on a SaaS model, the company is targeting recurring contracts with hospitals, universities, and healthcare payers across key regional markets, including Saudi Arabia, the UAE, and Egypt.
Merak Capital Bets on AI in Healthcare
The investment aligns with Merak Capital’s strategy of backing high-growth tech companies, particularly those using artificial intelligence to drive tangible results. The move also supports Saudi Arabia’s Vision 2030 goals for digital transformation and building knowledge-based industries.
Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said: “AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes. Backed by a team with deep industry experience, this represents the kind of innovation we are proud to support.”
Fueling Regional Growth
With the new funding, Hakeem Health plans to accelerate the institutional adoption of its HakeemDx platform across the GCC. The company aims to capitalize on the growing demand from regional healthcare systems for AI solutions that can boost clinical efficiency and quality of care.
Bilal Adi, Founder and CEO of Hakeem Health, stated: “Our mission is to help clinicians make better decisions, faster, so patients receive better care. Merak Capital’s investment reinforces that mission and supports the next phase of our growth. This funding enables us to expand our platform “HakeemDx” across hospitals and health systems in the GCC and continue building AI solutions that clinicians trust.”
About Hakeem Health
Hakeem Health is a KSA-based healthcare technology company on a mission to make AI-first clinical decision support the standard of care across the GCC. Its flagship platform, HakeemDx, equips clinicians with point-of-care intelligence built for the realities of regional health systems from JCI-accredited hospitals to national health authorities.
About Merak Capital
Merak Capital is a Saudi-based multi-strategy investment firm licensed by the Capital Market Authority. The firm manages over SAR 3 billion across 10 funds spanning venture capital, private equity, credit financing, and special projects. Merak partners with founders and enterprises driving transformation and enabling sustainable growth.
Source: Zawya
